Cargando…
Plasma miRNAs in predicting radiosensitivity in non-small cell lung cancer
BACKGROUND: Radioresistance of thoracic radiotherapy is a major bottleneck in the treatment of non-small cell lung cancer (NSCLC). Until now, there have been no effective biomarkers to predict the radiosensitivity. PURPOSES: Based on miRNA profile screened from NSCLC cell lines with different radios...
Autores principales: | Chen, Xu, Xu, Yanmei, Liao, Xingyun, Liao, Rongxia, Zhang, Luping, Niu, Kai, Li, Tao, Li, Dezhi, Chen, Zhengtang, Duan, Yuzhong, Sun, Jianguo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Netherlands
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5080326/ https://www.ncbi.nlm.nih.gov/pubmed/27075472 http://dx.doi.org/10.1007/s13277-016-5052-8 |
Ejemplares similares
-
Radiosensitizing effects of miR‐18a‐5p on lung cancer stem‐like cells via downregulating both ATM and HIF‐1α
por: Chen, Xu, et al.
Publicado: (2018) -
Feasibility study of DCs/CIKs combined with thoracic radiotherapy for patients with locally advanced or metastatic non-small-cell lung cancer
por: Zhang, Luping, et al.
Publicado: (2016) -
Clinical benefit from EGFR-TKI plus ginsenoside Rg3 in patients with advanced non-small cell lung cancer harboring EGFR active mutation
por: Li, Yan, et al.
Publicado: (2016) -
Induced cancer stem cells generated by radiochemotherapy and their therapeutic implications
por: Chen, Xiewan, et al.
Publicado: (2016) -
No Significant Difference between Plasma miRNAs and Plasma-Derived Exosomal miRNAs from Healthy People
por: Tian, Fei, et al.
Publicado: (2017)